These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37323765)

  • 1. Vonoprazan: A New Potassium-Competitive Acid Blocker.
    St Onge E; Phillips B
    J Pharm Technol; 2023 Jun; 39(3):139-146. PubMed ID: 37323765
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative Efficacy and Safety of Potassium-Competitive Acid Blockers vs. Proton Pump Inhibitors for Peptic Ulcer with or without
    Ouyang M; Zou S; Cheng Q; Shi X; Zhao Y; Sun M
    Pharmaceuticals (Basel); 2024 May; 17(6):. PubMed ID: 38931366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases.
    Inatomi N; Matsukawa J; Sakurai Y; Otake K
    Pharmacol Ther; 2016 Dec; 168():12-22. PubMed ID: 27514776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of
    Kanu JE; Soldera J
    World J Gastroenterol; 2024 Mar; 30(9):1213-1223. PubMed ID: 38577188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vonoprazan a novel potassium competitive acid blocker; another leap forward.
    Elsabaawy M; Shaban A; Al-Arab AE; Elbahr O; Edrees A; Afify S
    Prz Gastroenterol; 2024; 19(2):135-142. PubMed ID: 38939071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vonoprazan-based therapy for
    Akazawa Y; Fukuda D; Fukuda Y
    Therap Adv Gastroenterol; 2016 Nov; 9(6):845-852. PubMed ID: 27803739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study.
    Murakami K; Sakurai Y; Shiino M; Funao N; Nishimura A; Asaka M
    Gut; 2016 Sep; 65(9):1439-46. PubMed ID: 26935876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication.
    Jung YS; Kim EH; Park CH
    Aliment Pharmacol Ther; 2017 Jul; 46(2):106-114. PubMed ID: 28497487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of potassium-competitive acid blockers versus proton pump inhibitors as Helicobacter pylori eradication therapy: a meta-analysis of randomized clinical trials.
    Zhang M; Pang M; Zhang M
    Clinics (Sao Paulo); 2022; 77():100058. PubMed ID: 35810638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy.
    Ozaki H; Harada S; Takeuchi T; Kawaguchi S; Takahashi Y; Kojima Y; Ota K; Hongo Y; Ashida K; Sakaguchi M; Tokioka S; Sakamoto H; Furuta T; Tominaga K; Higuchi K
    Digestion; 2018; 97(3):212-218. PubMed ID: 29393194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of
    Yamada S; Kawakami T; Nakatsugawa Y; Suzuki T; Fujii H; Tomatsuri N; Nakamura H; Sato H; Okuyama Y; Kimura H; Yoshida N
    World J Gastrointest Pharmacol Ther; 2016 Nov; 7(4):550-555. PubMed ID: 27867688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vonoprazan With Amoxicillin or Amoxicillin and Clarithromycin for the Treatment of
    Liu L; Nahata MC
    Ann Pharmacother; 2023 Oct; 57(10):1185-1197. PubMed ID: 36688309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Vonoprazan for Helicobacter pylori Eradication.
    Kiyotoki S; Nishikawa J; Sakaida I
    Intern Med; 2020 Jan; 59(2):153-161. PubMed ID: 31243237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438).
    Otake K; Sakurai Y; Nishida H; Fukui H; Tagawa Y; Yamasaki H; Karashima M; Otsuka K; Inatomi N
    Adv Ther; 2016 Jul; 33(7):1140-57. PubMed ID: 27287852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vonoprazan fumarate for the management of acid-related diseases.
    Martinucci I; Blandizzi C; Bodini G; Marabotto E; Savarino V; Marchi S; de Bortoli N; Savarino E
    Expert Opin Pharmacother; 2017 Aug; 18(11):1145-1152. PubMed ID: 28657473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study.
    Gunaratne AW; Hamblin H; Clancy A; Magat AJMC; Dawson MVM; Tu J; Borody TJ
    Helicobacter; 2021 Oct; 26(5):e12830. PubMed ID: 34247436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data.
    Marabotto E; Ziola S; Savarino V; Giannini EG; Furnari M; Bodini G; Zingone F; Ghisa M; Barberio B; Zentilin P; Savarino E
    Clin Exp Gastroenterol; 2020; 13():99-104. PubMed ID: 32346304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication rate and safety of a "simplified rescue therapy": 14-day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in eradication: A real-world, retrospective clinical study in China.
    Gao W; Teng G; Wang C; Xu Y; Li Y; Cheng H
    Helicobacter; 2022 Oct; 27(5):e12918. PubMed ID: 35877765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice.
    Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Mochizuki S; Matsuo K; Isomura Y; Seto M; Suzuki N; Suzuki H; Yamamoto S; Sugimoto T; Omae T; Okamoto M; Watabe H; Togo G; Takano N; Fukui K; Ito Y; Koike K
    J Dig Dis; 2016 Oct; 17(10):670-675. PubMed ID: 27534444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.